SCHEMBL6174668

SCHEMBL6174668

CC(c1ccnc2c(N(C)C)cccc12)C1(C(C)c2ccnc3c(N(C)C)cccc23)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 17/20 0.39
NTRK1 P04629 1/20 0.32
TRPV4 Q9HBA0 1/20 0.32
AR P10275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174376 0.86 IGF1R (0.39) IGF1RAR
SCHEMBL6176288 0.86 IGF1R (0.39) IGF1RNTRK1
SCHEMBL6172723 0.85 IGF1R (0.41) IGF1RAR
SCHEMBL6172470 0.83 IGF1R (0.36) IGF1RNTRK1TRPV4
SCHEMBL6174905 0.81 IGF1R (0.41) IGF1RAR
SCHEMBL6172720 0.81 IGF1R (0.41) IGF1RAR
SCHEMBL6174696 0.80 SMN1; SMN2 (0.41) IGF1RAR
SCHEMBL6174877 0.79 IGF1R (0.43) IGF1RNTRK1
SCHEMBL6174880 0.79 IGF1R (0.36) IGF1RNTRK1TRPV4
SCHEMBL6174509 0.79 IGF1R (0.39) IGF1RNTRK1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed